{"id":"W4406785134","doi":"10.1093/bjd/ljae507","title":"Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Atopic dermatitis; Placebo; Medicine; Dose-ranging study; Multicenter study; Dermatology; Internal medicine; Randomized controlled trial; Double blind; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004156078,0.001586317,0.002512342,0.000523346,0.0004741415,0.0009024063,0.0009304273,0.001545518,0.0050096],"category_scores_gemma":[0.001799056,0.0007996149,0.002083947,0.0005297778,0.0009734988,0.0008257743,0.0004648518,0.002257749,0.0006624451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005365799,"about_ca_system_score_gemma":0.001108102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005491828,"about_ca_topic_score_gemma":0.001831185,"domain_scores_codex":[0.9990613,0.0005232699,0.00007947097,0.0001275459,0.00008609505,0.0001223998],"domain_scores_gemma":[0.9988614,0.0002385983,0.0003001717,0.0001020915,0.0001034034,0.0003943049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9373726,0.01903601,0.00272034,0.00106984,0.001308041,0.00007685537,0.0001162851,0.0004233565,0.01259372,0.00006145076,0.0009906708,0.02423081],"study_design_scores_gemma":[0.855732,0.1358973,0.006246858,0.00003423288,0.0005929344,0.00006518892,0.00001671205,0.0001428406,0.0006252741,0.00004763174,0.0005864986,0.00001270303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863567,0.005525105,0.0005104344,0.0003779453,0.0001420563,0.00465791,0.00112912,0.00008094643,0.001219678],"genre_scores_gemma":[0.9854223,0.003476072,0.001968297,0.0009748806,0.0003320331,0.004360157,0.001631639,0.0000234932,0.001811345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0050096,"threshold_uncertainty_score":0.02197975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006689492097948261,"score_gpt":0.2768975909451721,"score_spread":0.2702080988472238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}